Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1989 Oct;33(10):1662–1667. doi: 10.1128/aac.33.10.1662

Treatment of genitourinary tract infections with fluoroquinolones: clinical efficacy in genital infections and adverse effects.

D C Hooper 1, J S Wolfson 1
PMCID: PMC172734  PMID: 2686546

Full text

PDF
1662

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allais J. M., Preheim L. C., Cuevas T. A., Roccaforte J. S., Mellencamp M. A., Bittner M. J. Randomized, double-blind comparison of ciprofloxacin and trimethoprim-sulfamethoxazole for complicated urinary tract infections. Antimicrob Agents Chemother. 1988 Sep;32(9):1327–1330. doi: 10.1128/aac.32.9.1327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arcieri G., Griffith E., Gruenwaldt G., Heyd A., O'Brien B., Becker N., August R. Ciprofloxacin: an update on clinical experience. Am J Med. 1987 Apr 27;82(4A):381–386. [PubMed] [Google Scholar]
  3. Ariyarit C., Panikabutra K., Chitwarakorn A., Wongba C., Buatiang A. Efficacy of ofloxacin in uncomplicated gonorrhoea. Infection. 1986;14 (Suppl 4):S311–S313. doi: 10.1007/BF01661304. [DOI] [PubMed] [Google Scholar]
  4. Bakhtiar M., Samarasinghe P. L. Enoxacin as one day oral treatment of men with anal or pharyngeal gonorrhoea. Genitourin Med. 1988 Dec;64(6):364–366. doi: 10.1136/sti.64.6.364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bischoff W. Ofloxacin: therapeutic results in Chlamydia trachomatis urethritis. Infection. 1986;14 (Suppl 4):S316–S317. doi: 10.1007/BF01661306. [DOI] [PubMed] [Google Scholar]
  6. Black J. R., Long J. M., Zwickl B. E., Ray B. S., Verdon M. S., Wetherby S., Hook E. W., 3rd, Handsfield H. H. Multicenter randomized study of single-dose ofloxacin versus amoxicillin-probenecid for treatment of uncomplicated gonococcal infection. Antimicrob Agents Chemother. 1989 Feb;33(2):167–170. doi: 10.1128/aac.33.2.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bodhidatta L., Taylor D. N., Chitwarakorn A., Kuvanont K., Echeverria P. Evaluation of 500- and 1,000-mg doses of ciprofloxacin for the treatment of chancroid. Antimicrob Agents Chemother. 1988 May;32(5):723–725. doi: 10.1128/aac.32.5.723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Boerema J. B., Moesker H. L., Notowicz, Van de Rhee H. J. Fleroxacin (Ro 23-6240) in the treatment of gonorrhoea. J Antimicrob Chemother. 1988 Jan;21(1):140–141. doi: 10.1093/jac/21.1.140. [DOI] [PubMed] [Google Scholar]
  9. Bogaerts J., Martinez Tello W., Verbist L., Piot P., Vandepitte J. Norfloxacin versus thiamphenicol for treatment of uncomplicated gonorrhea in Rwanda. Antimicrob Agents Chemother. 1987 Mar;31(3):434–437. doi: 10.1128/aac.31.3.434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bowie W. R., Willetts V., Sibau L. Failure of norfloxacin to eradicate Chlamydia trachomatis in nongonococcal urethritis. Antimicrob Agents Chemother. 1986 Oct;30(4):594–597. doi: 10.1128/aac.30.4.594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Calderón E., Conde-Glez C., Echaniz G., Arredondo J. L., Olvera J., Hirata C., Villafaña M. Results of treatment of uncomplicated urogenital gonorrhoea with enoxacin compared with ceftriaxone. Int J Clin Pharmacol Res. 1988;8(4):247–251. [PubMed] [Google Scholar]
  12. Campoli-Richards D. M., Monk J. P., Price A., Benfield P., Todd P. A., Ward A. Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs. 1988 Apr;35(4):373–447. doi: 10.2165/00003495-198835040-00003. [DOI] [PubMed] [Google Scholar]
  13. Chan A. S., Tang K. C., Fung K. K., Ng T. K. Single dose ofloxacin in treatment of uncomplicated gonorrhoea. Infection. 1986;14 (Suppl 4):S314–S315. doi: 10.1007/BF01661305. [DOI] [PubMed] [Google Scholar]
  14. Crawford J., Eye-Boland M. K., Cohen H. J. Clinical utility of erythrocyte sedimentation rate and plasma protein analysis in the elderly. Am J Med. 1987 Feb;82(2):239–246. doi: 10.1016/0002-9343(87)90063-5. [DOI] [PubMed] [Google Scholar]
  15. Crider S. R., Colby S. D., Miller L. K., Harrison W. O., Kerbs S. B., Berg S. W. Treatment of penicillin-resistant Neisseria gonorrhoeae with oral norfloxacin. N Engl J Med. 1984 Jul 19;311(3):137–140. doi: 10.1056/NEJM198407193110301. [DOI] [PubMed] [Google Scholar]
  16. Fernandes P. B., Chu D. T., Swanson R. N., Ramer N. R., Hanson C. W., Bower R. R., Stamm J. M., Hardy D. J. A-61827 (A-60969), a new fluoronaphthyridine with activity against both aerobic and anaerobic bacteria. Antimicrob Agents Chemother. 1988 Jan;32(1):27–32. doi: 10.1128/aac.32.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Fong I. W., Linton W., Simbul M., Thorup R., McLaughlin B., Rahm V., Quinn P. A. Treatment of nongonococcal urethritis with ciprofloxacin. Am J Med. 1987 Apr 27;82(4A):311–316. [PubMed] [Google Scholar]
  18. Foot M., Williams G., Want S., Roe M., Quaghebeur G., Bates S. An open study of the safety and efficacy of enoxacin in complicated urinary tract infections. J Antimicrob Chemother. 1988 Feb;21 (Suppl B):97–103. doi: 10.1093/jac/21.suppl_b.97. [DOI] [PubMed] [Google Scholar]
  19. Fransen L., Avonts D., Piot P. Treatment of genital chlamydial infection with ofloxacin. Infection. 1986;14 (Suppl 4):S318–S320. doi: 10.1007/BF01661307. [DOI] [PubMed] [Google Scholar]
  20. Goldstein E. J., Kahn R. M., Alpert M. L., Ginsberg B. P., Greenway F. L., Citron D. M. Ciprofloxacin versus cinoxacin in therapy of urinary tract infections. A randomized, double-blind trial. Am J Med. 1987 Apr 27;82(4A):284–287. [PubMed] [Google Scholar]
  21. Henry N. K., Schultz H. J., Grubbs N. C., Muller S. M., Ilstrup D. M., Wilson W. R. Comparison of ciprofloxacin and co-trimoxazole in the treatment of uncomplicated urinary tract infection in women. J Antimicrob Chemother. 1986 Nov;18 (Suppl 500):103–106. doi: 10.1093/jac/18.supplement_d.103. [DOI] [PubMed] [Google Scholar]
  22. Hooper D. C., Wolfson J. S. The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans. Antimicrob Agents Chemother. 1985 Nov;28(5):716–721. doi: 10.1128/aac.28.5.716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Huttunen M., Kunnas K., Saloranta P. Enoxacin treatment of urinary tract infections in elderly patients. J Antimicrob Chemother. 1988 Feb;21 (Suppl B):105–111. doi: 10.1093/jac/21.suppl_b.105. [DOI] [PubMed] [Google Scholar]
  24. Hägele D., Chyský V. Is pelvic inflammatory disease an indication for treatment with ciprofloxacin? Infection. 1988;16 (Suppl 1):S48–S50. doi: 10.1007/BF01650507. [DOI] [PubMed] [Google Scholar]
  25. Kaplowitz L. G., Vishniavsky N., Evans T., Vartivarian S., Dalton H., Simpson M., Gruninger R. P. Norfloxacin in the treatment of uncomplicated gonococcal infections. Am J Med. 1987 Jun 26;82(6B):35–39. doi: 10.1016/0002-9343(87)90616-4. [DOI] [PubMed] [Google Scholar]
  26. Kromann-Andersen B., Sommer P., Pers C., Larsen V., Rasmussen F. Ofloxacin compared with ciprofloxacin in the treatment of complicated lower urinary tract infections. J Antimicrob Chemother. 1988 Sep;22 (Suppl 100):143–147. doi: 10.1093/jac/22.supplement_c.143. [DOI] [PubMed] [Google Scholar]
  27. Lassus A., Renkonen O. V., Ellmén J. Fleroxacin versus standard therapy in gonococcal urethritis. J Antimicrob Chemother. 1988 Oct;22 (Suppl 500):223–225. doi: 10.1093/jac/22.supplement_d.223. [DOI] [PubMed] [Google Scholar]
  28. Loo P. S., Ridgway G. L., Oriel J. D. Single dose ciprofloxacin for treating gonococcal infections in men. Genitourin Med. 1985 Oct;61(5):302–305. doi: 10.1136/sti.61.5.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Mehtar S., Drabu Y., Blakemore P. Ciprofloxacin in the treatment of infections caused by gentamicin-resistant gram-negative bacteria. Eur J Clin Microbiol. 1986 Apr;5(2):248–251. doi: 10.1007/BF02014001. [DOI] [PubMed] [Google Scholar]
  30. Mensing H. Treatment of chancroid with enoxacin. Acta Derm Venereol. 1985;65(5):455–457. [PubMed] [Google Scholar]
  31. Monk J. P., Campoli-Richards D. M. Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs. 1987 Apr;33(4):346–391. doi: 10.2165/00003495-198733040-00003. [DOI] [PubMed] [Google Scholar]
  32. Naamara W., Kunimoto D. Y., D'Costa L. J., Ndinya-Achola J. O., Nsanze H., Ronald A. R., Plummer F. A. Treating chancroid with enoxacin. Genitourin Med. 1988 Jun;64(3):189–192. doi: 10.1136/sti.64.3.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Naamara W., Plummer F. A., Greenblatt R. M., D'Costa L. J., Ndinya-Achola J. O., Ronald A. R. Treatment of chancroid with ciprofloxacin. A prospective, randomized clinical trial. Am J Med. 1987 Apr 27;82(4A):317–320. [PubMed] [Google Scholar]
  34. Nayagam A. T., Ridgway G. L., Oriel J. D. Efficacy of ofloxacin in the treatment of non-gonococcal urethritis in men and genital infections caused by Chlamydia trachomatis in men and women. J Antimicrob Chemother. 1988 Sep;22 (Suppl 100):155–158. doi: 10.1093/jac/22.supplement_c.155. [DOI] [PubMed] [Google Scholar]
  35. Noble M. A., Chan V. Ciprofloxacin treatment of Salmonella hadar epididymo-orchitis. J Antimicrob Chemother. 1988 Mar;21(3):383–384. doi: 10.1093/jac/21.3.383. [DOI] [PubMed] [Google Scholar]
  36. Notowicz A., Stolz E., van Klingeren B. A double blind study comparing two dosages of enoxacin for the treatment of uncomplicated urogenital gonorrhoea. J Antimicrob Chemother. 1984 Sep;14 (Suppl 100):91–94. doi: 10.1093/jac/14.suppl_c.91. [DOI] [PubMed] [Google Scholar]
  37. Novick N. L., Tapia L., Bottone E. J. Invasive trichophyton rubrum infection in an immunocompromised host. Case report and review of the literature. Am J Med. 1987 Feb;82(2):321–325. doi: 10.1016/0002-9343(87)90078-7. [DOI] [PubMed] [Google Scholar]
  38. Panikabutra K., Lee C. T., Ho B., Bamberg P. Single dose oral norfloxacin or intramuscular spectinomycin to treat gonorrhoea (PPNG and non-PPNG infections): analysis of efficacy and patient preference. Genitourin Med. 1988 Aug;64(4):235–240. doi: 10.1136/sti.64.4.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Pust R. A., Ackenheil-Köppe H. R., Weidner W., Meier-Ewert H. Clinical efficacy and tolerance of fleroxacin in patients with urethritis caused by Chlamydia trachomatis. J Antimicrob Chemother. 1988 Oct;22 (Suppl 500):227–230. doi: 10.1093/jac/22.supplement_d.227. [DOI] [PubMed] [Google Scholar]
  40. Ramirez C. A., Bran J. L., Mejia C. R., Garcia J. F. Open, prospective study of the clinical efficacy of ciprofloxacin. Antimicrob Agents Chemother. 1985 Jul;28(1):128–132. doi: 10.1128/aac.28.1.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Richmond S. J., Bhattacharyya M. N., Maiti H., Chowdhury F. H., Stirland R. M., Tooth J. A. The efficacy of ofloxacin against infection caused by Neisseria gonorrhoeae and Chlamydia trachomatis. J Antimicrob Chemother. 1988 Sep;22 (Suppl 100):149–153. doi: 10.1093/jac/22.supplement_c.149. [DOI] [PubMed] [Google Scholar]
  42. Roddy R. E., Handsfield H. H., Hook E. W., 3rd Comparative trial of single-dose ciprofloxacin and ampicillin plus probenecid for treatment of gonococcal urethritis in men. Antimicrob Agents Chemother. 1986 Aug;30(2):267–269. doi: 10.1128/aac.30.2.267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Romanowski B., Wood H., Draker J., Tsianco M. C. Norfloxacin in the therapy of uncomplicated gonorrhea. Antimicrob Agents Chemother. 1986 Sep;30(3):514–515. doi: 10.1128/aac.30.3.514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Schaeffer A. J. Multiclinic study of norfloxacin for treatment of urinary tract infections. Am J Med. 1987 Jun 26;82(6B):53–58. doi: 10.1016/0002-9343(87)90619-x. [DOI] [PubMed] [Google Scholar]
  45. Scott G. R., McMillan A., Young H. Ciprofloxacin versus ampicillin and probenecid in the treatment of uncomplicated gonorrhoea in men. J Antimicrob Chemother. 1987 Jul;20(1):117–121. doi: 10.1093/jac/20.1.117. [DOI] [PubMed] [Google Scholar]
  46. Shahmanesh M., Shukla S. R., Phillips I., Westwood A., Thin R. N. Ciprofloxacin for treating urethral gonorrhoea in men. Genitourin Med. 1986 Apr;62(2):86–87. doi: 10.1136/sti.62.2.86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Sheehan G. J., Harding G. K., Haase D. A., Thomson M. J., Urias B., Kennedy J. K., Hoban D. J., Ronald A. R. Double-blind, randomized comparison of 24 weeks of norfloxacin and 12 weeks of norfloxacin followed by 12 weeks of placebo in the therapy of complicated urinary tract infection. Antimicrob Agents Chemother. 1988 Aug;32(8):1292–1293. doi: 10.1128/aac.32.8.1292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Siboulet A., Bohbot J. M., Catalan F. Enoxacin in the treatment of sexually transmitted diseases. J Antimicrob Chemother. 1988 Feb;21 (Suppl B):119–124. doi: 10.1093/jac/21.suppl_b.119. [DOI] [PubMed] [Google Scholar]
  49. Sneller M., Wellborne F., Barile M. F., Plotz P. Prosthetic joint infection with Mycoplasma hominis. J Infect Dis. 1986 Jan;153(1):174–175. doi: 10.1093/infdis/153.1.174. [DOI] [PubMed] [Google Scholar]
  50. Stamm W. E. Problems in the treatment of bacterial sexually transmitted diseases. Am J Med. 1987 Apr 27;82(4A):307–310. [PubMed] [Google Scholar]
  51. Stein G. E., Mummaw N., Goldstein E. J., Boyko E. J., Reller L. B., Kurtz T. O., Miller K., Cox C. E. A multicenter comparative trial of three-day norfloxacin vs ten-day sulfamethoxazole and trimethoprim for the treatment of uncomplicated urinary tract infections. Arch Intern Med. 1987 Oct;147(10):1760–1762. [PubMed] [Google Scholar]
  52. Swanson B. N., Boppana V. K., Vlasses P. H., Rotmensch H. H., Ferguson R. K. Norfloxacin disposition after sequentially increasing oral doses. Antimicrob Agents Chemother. 1983 Feb;23(2):284–288. doi: 10.1128/aac.23.2.284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Tegelberg-Stassen M. J., van der Hoek J. C., Mooi L., Wagenvoort J. H., van Joost T., Michel M. F., Stolz E. Treatment of uncomplicated gonococcal urethritis in men with two dosages of ciprofloxacin. Eur J Clin Microbiol. 1986 Apr;5(2):244–246. doi: 10.1007/BF02013999. [DOI] [PubMed] [Google Scholar]
  54. Tegelberg-Stassen M. J., van der Willigen A. H., van der Hoek J. C., Wagenvoort J. H., van Vliet H. J., van Klingeren B., van Joost T., Michel M. F., Stolz E. Treatment of uncomplicated urogenital gonorrhoea in women with a single dose of enoxacin. Eur J Clin Microbiol. 1986 Aug;5(4):395–398. doi: 10.1007/BF02075693. [DOI] [PubMed] [Google Scholar]
  55. Traisupa A., Wongba C., Tesavibul P. Efficacy and safety of a single dose therapy of a 500 mg ciprofloxacin tablet in chancroid patients. Infection. 1988;16 (Suppl 1):S44–S45. doi: 10.1007/BF01650505. [DOI] [PubMed] [Google Scholar]
  56. Une T., Nakajima R., Otani T., Katami K., Osada Y., Otani M. Lack of effectiveness of ofloxacin against experimental syphilis in rabbits. Arzneimittelforschung. 1987 Sep;37(9):1048–1051. [PubMed] [Google Scholar]
  57. Veller-Fornasa C., Tarantello M., Cipriani R., Guerra L., Peserico A. Effect of ofloxacin on Treponema pallidum in incubating experimental syphilis. Genitourin Med. 1987 Jun;63(3):214–214. doi: 10.1136/sti.63.3.214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Wang C., Sabbaj J., Corrado M., Hoagland V. World-wide clinical experience with norfloxacin: efficacy and safety. Scand J Infect Dis Suppl. 1986;48:81–89. [PubMed] [Google Scholar]
  59. Weidner W., Schiefer H. G., Garbe C. Acute nongonococcal epididymitis. Aetiological and therapeutic aspects. Drugs. 1987;34 (Suppl 1):111–117. doi: 10.2165/00003495-198700341-00024. [DOI] [PubMed] [Google Scholar]
  60. Wijnands W. J., Vree T. B. Interaction between the fluoroquinolones and the bronchodilator theophylline. J Antimicrob Chemother. 1988 Sep;22 (Suppl 100):109–114. doi: 10.1093/jac/22.supplement_c.109. [DOI] [PubMed] [Google Scholar]
  61. Wise R., Ashby J. P., Andrews J. M. In vitro activity of PD 127,391, an enhanced-spectrum quinolone. Antimicrob Agents Chemother. 1988 Aug;32(8):1251–1256. doi: 10.1128/aac.32.8.1251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Wolfson J. S., Hooper D. C. Fluoroquinolone antimicrobial agents. Clin Microbiol Rev. 1989 Oct;2(4):378–424. doi: 10.1128/cmr.2.4.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Wolfson J. S., Hooper D. C. Treatment of genitourinary tract infections with fluoroquinolones: activity in vitro, pharmacokinetics, and clinical efficacy in urinary tract infections and prostatitis. Antimicrob Agents Chemother. 1989 Oct;33(10):1655–1661. doi: 10.1128/aac.33.10.1655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. van der Willigen A. H., van der Hoek J. C., Wagenvoort J. H., van Vliet H. J., van Klingeren B., Schalla W. O., Knapp J. S., van Joost T., Michel M. F., Stolz E. Comparative double-blind study of 200- and 400-mg enoxacin given orally in the treatment of acute uncomplicated urethral gonorrhea in males. Antimicrob Agents Chemother. 1987 Apr;31(4):535–538. doi: 10.1128/aac.31.4.535. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES